Start with its own history
At 25.11×, CAH is 27.8% below its 8-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

Current valuation, historical context, and peer comparisons.
Current P/E ratio
25.11×
27.8% belowthe 8-observation annual average
Price and EPS in quote currency. Calculation details
Investors are paying 25.11 for every 1 of reported earnings per share.
Annual period-end data · 25 observations
| Period end | P/E | Change |
|---|---|---|
| Jun 30, 2026 | 32.68× | +26.0% |
| Jun 30, 2025 | 25.93× | -7.7% |
| Jun 30, 2024 | 28.09× | -62.6% |
| Jun 30, 2023 | 75.06× | N/M |
| Jun 30, 2022 | N/M | N/M |
| Jun 30, 2021 | 27.32× | N/M |
| Jun 30, 2020 | N/M | N/M |
| Jun 30, 2019 | 10.48× | -82.4% |
| Period end | P/E | Change |
|---|---|---|
| Jun 30, 2018 | 59.55× | +210.3% |
| Jun 30, 2017 | 19.19× | +7.3% |
| Jun 30, 2016 | 17.89× | -21.7% |
| Jun 30, 2015 | 22.86× | +14.0% |
| Jun 30, 2014 | 20.05× | -58.7% |
| Jun 30, 2013 | 48.56× | +258.4% |
| Jun 30, 2012 | 13.55× | -18.0% |
| Jun 30, 2011 | 16.52× | -12.0% |
| Jun 30, 2010 | 18.78× | +97.9% |
| Jun 30, 2009 | 9.49× | -33.2% |
| Jun 30, 2008 | 14.21× | -1.6% |
| Jun 30, 2007 | 14.45× | -46.6% |
| Jun 30, 2006 | 27.03× | +14.5% |
| Jun 30, 2005 | 23.60× | +14.2% |
| Jun 30, 2004 | 20.66× | -1.0% |
| Jun 30, 2003 | 20.88× | -13.7% |
| Jun 30, 2002 | 24.18× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
CAH This stockCardinal Health, Inc. | 25.11× |
MCKMcKesson Corporation | 27.36× |
CORCencora, Inc. | 19.68× |
HSICHenry Schein, Inc. | 23.91× |
SHTDYSinopharm Group Co. Ltd. | 6.31× |
SHPMYShanghai Pharmaceuticals Holding Co., Ltd | 12.13× |
SIG.AXSigma Healthcare Limited | 45.70× |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
At 25.11×, CAH is 27.8% below its 8-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
The median of the 6 positive peer ratios above is 21.80×. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore Wisesheets=WISE("CAH", "PE Ratio", "LQ")Share price 261.93 ÷ EPS 10.43 = 25.11×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 4, 2026; this is not a real-time trading quote.
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
The essentials behind the numbers.
Cardinal Health, Inc.'s current P/E is 25.11× based on the quote data last updated Nov 4, 2026. It represents the share price divided by reported earnings per share. Prices and earnings may refresh on different schedules.
Annual P/E uses earnings for a completed fiscal year. Trailing-12-month (TTM) P/E uses the latest four quarters, while forward P/E uses forecast earnings. These are not interchangeable. This page labels peer ratios as TTM and shows dated annual or quarterly historical observations; it does not show forward estimates.
N/M means not meaningful: the feed has no positive P/E for that observation. Negative or zero earnings should not be ranked as a low positive valuation multiple. N/M observations are excluded from the averages shown above.
Divide the share price by earnings per share (EPS). For example, a share price of 100 and EPS of 5 gives a P/E of 20×. This page uses the price and EPS supplied together in the quote when both are positive.
Price timestamps, EPS definitions, share classes, adjustments, and fiscal periods can differ. A forward P/E also uses forecast earnings rather than reported earnings. Compare the inputs and as-of dates before comparing two displayed ratios.
Not necessarily. The average describes previous market pricing, not fair value. Changes in earnings quality, growth expectations, debt, accounting, and business risk can justify a different multiple today.